Black Diamond Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Black Diamond Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $475k | 109k | 4.35 |
2024-06-30 | $476k | 102k | 4.66 |
2024-03-31 | $73k | 15k | 5.07 |
2023-12-31 | $41k | 15k | 2.81 |
2023-09-30 | $42k | 15k | 2.87 |
2023-06-30 | $73k | 15k | 5.05 |
2022-06-30 | $45k | 18k | 2.50 |
2022-03-31 | $134k | 48k | 2.78 |
2021-12-31 | $322k | 60k | 5.34 |
2021-09-30 | $511k | 60k | 8.47 |
2021-06-30 | $1.4M | 119k | 12.19 |
2021-03-31 | $2.8M | 115k | 24.26 |
2020-12-31 | $3.5M | 108k | 32.05 |
2020-09-30 | $3.2M | 107k | 30.23 |
2020-06-30 | $3.4M | 81k | 42.16 |
2020-03-31 | $638k | 26k | 24.97 |